Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-00062 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2780-00062 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2720-00062 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2796-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-00062 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-00062 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-141 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-102 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-711 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 |
filingDate |
2018-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2020-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2020513783-A |
titleOfInvention |
CRISPR |
abstract |
A lysogenic virus comprising a vector encoding isolated nucleic acid encoding two or more gene editors selected from viral DNA targeting gene editors, viral RNA targeting gene editors, and combinations thereof. A composition for treating. A composition for treating a lytic virus comprising a vector encoding an isolated nucleic acid encoding at least one gene editor targeting viral DNA and a viral RNA targeting composition. A composition for treating both lysogenic and lytic viruses comprising a vector encoding isolated nucleic acids encoding two or more gene editors targeting viral RNA. A composition for treating a lytic virus. A method for treating a lysogenic virus or a lytic virus by administering the above composition to an individual having a virus and inactivating the virus. [Selection diagram] Figure 1 |
priorityDate |
2017-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |